Shared Causal Paths underlying Alzheimer’s dementia and Type 2 Diabetes

被引:0
|
作者
Zixin Hu
Rong Jiao
Panpan Wang
Yun Zhu
Jinying Zhao
Phil De Jager
David A. Bennett
Li Jin
Momiao Xiong
机构
[1] State Key Laboratory of Genetic Engineering and Innovation Center of Genetics and Development,Department of Epidemiology
[2] School of Life Sciences,undefined
[3] Fudan University,undefined
[4] Department of Biostatistics and Data Science,undefined
[5] School of Public Health,undefined
[6] University of Texas Health Science Center at Houston,undefined
[7] Human Phenome Institute,undefined
[8] Fudan University,undefined
[9] University of Florida,undefined
[10] Center for Translational & Computational Neuroimmunology,undefined
[11] Department of Neurology,undefined
[12] Columbia University Medical Center,undefined
[13] Rush Alzheimer’s Disease Center,undefined
[14] Rush University Medical Center,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Although Alzheimer’s disease (AD) is a central nervous system disease and type 2 diabetes MELLITUS (T2DM) is a metabolic disorder, an increasing number of genetic epidemiological studies show clear link between AD and T2DM. The current approach to uncovering the shared pathways between AD and T2DM involves association analysis; however such analyses lack power to discover the mechanisms of the diseases. As an alternative, we developed novel causal inference methods for genetic studies of AD and T2DM and pipelines for systematic multi-omic casual analysis to infer multilevel omics causal networks for the discovery of common paths from genetic variants to AD and T2DM. The proposed pipelines were applied to 448 individuals from the ROSMAP Project. We identified 13 shared causal genes, 16 shared causal pathways between AD and T2DM, and 754 gene expression and 101 gene methylation nodes that were connected to both AD and T2DM in multi-omics causal networks.
引用
下载
收藏
相关论文
共 50 条
  • [41] ALZHEIMER'S DISEASE: A NEURODEGENERATIVE TYPE OF DEMENTIA
    Rahman, Md. Mosiqur
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 3 (01): : 18 - 21
  • [42] Functional neuroimaging in Alzheimer's type dementia
    Demetriades, AK
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 203 : 247 - 251
  • [43] Naming and knowing in dementia of Alzheimer's type
    Hodges, JR
    Patterson, K
    Graham, N
    Dawson, K
    BRAIN AND LANGUAGE, 1996, 54 (02) : 302 - 325
  • [44] Enhancing communication in dementia of the Alzheimer's type
    Orange, JB
    Colton-Hudson, A
    TOPICS IN GERIATRIC REHABILITATION, 1998, 14 (02) : 56 - 75
  • [45] Referential communication in Alzheimer's type dementia
    Carlomagno, S
    Santoro, A
    Menditti, A
    Pandolfi, M
    Marini, A
    CORTEX, 2005, 41 (04) : 520 - 534
  • [46] Diabetes and risk of Alzheimer's disease and vascular dementia
    Luchsinger, J
    Tang, MX
    Jacobs, D
    Stern, Y
    Moroney, J
    Shea, S
    Mayeux, R
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (08) : S32 - S32
  • [47] Factors Underlying Caregiver Stress in Frontotemporal Dementia and Alzheimer's Disease
    Mioshi, Eneida
    Bristow, Matt
    Cook, Rachel
    Hodges, John R.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 27 (01) : 76 - 81
  • [48] Potential Roles of Peroxisomes in Alzheimer's Disease and in Dementia of the Alzheimer's Type
    Lizard, Gerard
    Rouaud, Olivier
    Demarquoy, Jean
    Cherkaoui-Malki, Mustapha
    Iuliano, Luigi
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 29 (02) : 241 - 254
  • [49] Neurodegeneration in type 2 diabetes: Alzheimer's as a case study
    Madhusudhanan, Jalaja
    Suresh, Gowthaman
    Devanathan, Vasudharani
    BRAIN AND BEHAVIOR, 2020, 10 (05):
  • [50] Iron, type 2 diabetes mellitus, and Alzheimer’s disease
    Luca Mascitelli
    Francesca Pezzetta
    Mark R. Goldstein
    Cellular and Molecular Life Sciences, 2009, 66 : 2943 - 2943